gip glp 1 glucagon agonists Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes GLP-1 Receptor Agonists – Peripheral

Humana blocks Wegovy for weight loss using automated diagnosis code editsnot PA denials

Ultrasound assessments could improve risk stratification for perioperative management

Despite the potential clinical benefits of GLP-1RA plus SGLT2i combination therapy in patients with T2DM, several factors may delay this combination to become a common practice soon, such as reimbursement and costs associated with polypharmacy

Here the authors report that D-allulose triggers GLP-1 release in the gut and GLP-1R signaling on vagal afferents, counteracting arrhythmic overeating, obesity and diabetes.

Postprandial reduction in hunger was greater after RYGB than OAGB from baseline to 12 months